Stryker is one of the world’s leading medical technology companies and, together with our customers, is driven to make healthcare better. We offer innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. We are proud to be named one of the World’s Best Workplaces and a Best Workplace for Diversity by Fortune Magazine. Learn more about our award-winning organization by visiting stryker.com
The Senior Analyst, Financial Reporting of the Financial Consolidations and Reporting Systems team is an integral member of the Controller's group and the Flower Mound Finance Center. This position will be primarily responsible for supporting the preparation of worldwide consolidated financial statements, as well as the consolidation of projections and budgets.
What you will do
Assistance with the preparation, consolidation, analytical review and delivery of the worldwide consolidated financial statements including flash and actual results and analysis of the product line P&L in compliance and alignment with Stryker's policies and Regulatory bodies
Assist end users in troubleshooting system usage issues. Must be able to independently research/troubleshoot/resolve financial reporting and system related issues.
Create/update data input tools for end users, including Smart View templates for month-end close, budget, and projection loading.
Work with locations to implement Financial Data Quality Management (FDM) or improve the efficiency of their FDM or Smart View loading process
Provide top tier end user support; Monitor and respond to shared inboxes, HFM ServiceNow tickets, and other support tools during and after standard work hours
Perform Divisional Financial Statement Reviews and assist in coordination of the Financial Statement Review process
Complete Ad Hoc financial statement analysis as requested.
Provide assistance to the FP&A department in consolidation and review of projections, strategic plans, and annual budget
Assistant with monitoring Intercompany matching and eliminations at the consolidated Stryker level
Drive continuous improvement in our month end close/consolidation, planning, and reporting processes
Support preparation of cash flow statements, earnings release calculations, equity footnotes and other equity related disclosures.
Support the audit requirements collaboratively with both Stryker Internal Audit and external auditors.
Support Hyperion System team with testing and other tasks as necessary.
What you need
2+ years accounting or related experience including Industry and Public Accounting
Familiarity with key financial statements (Income Statement, Balance Sheet, and Cash flow statement)
Extensive experience with Hyperion preferred (including HFM, Hyperion Planning, FDM, and Smart View)
Strong knowledge of US GAAP
Excellent problem solving skills
Advanced Excel skills
Strong analytical, organizational, and communication (both oral and written) skills required
Ability to pay strong attention to detail
Ability to work in a team environment
Ability to maintain poise and positive attitude when working through difficult issues with end users while managing competing deadlines
Stryker is one of the world's leading medical technology companies and, together with our customers, we are driven to make healthcare better. The Company offers a diverse array of innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. Stryker is active in over 100 countries around the world.
Together with our customers, we are driven to make healthcare better.
At Stryker, quality is first in everything we do. We are driven to make healthcare better for our customers by
providing innovative products and services that meet regulatory requirements through our effective quality system.
The Company was founded in 1941 by Dr. Homer Stryker and incorporated in 1946 as the Orthopedic Frame Company. In 1964, the Company’s name was changed to Stryker Corporation.
• $13.6 billion in annual sales in 2018; annual revenue has grown for 39 straight years
• 17.1% CAGR (compound annual growth rate) in sales over 39 years
• ~36,000 employees globally in 2018
• 43 manufacturing and research & development locat...ions worldwide
• Included in the Standard & Poor’s 500 Index
• Ranked # 233 on Fortune Magazine’s “FORTUNE 500” list for 2019
• Ranked # 3 on Fortune Magazine’s “World’s Most Admired Companies” list for the “Medical Equipment” industry for 2019
• Ranked # 11 on Fortune Magazine’s “100 Best Companies to Work For” list (U.S.) for 2019
• Spent $862 million on R&D in 2018
• 7,784 patents owned globally in 2018
• Initial public offering of stock was in 1979
• Listed on the New York Stock Exchange under ticker SYK